On the other hand, 21 genes (CD3D, CD9, CD11b, CD14, CD18, CD24, CD37, CD50, CD52, CD62L, CD66b, CD66c, CD83, CD87, CD88, CD98, CD210A, CD282, CD339, CD354, and CD369) were differentially expressed between both at least two different AML subgroups and one AML subgroup compared to normal samples (Table 2 and Table 3). This evidence concerns the gene TREM1 and acute myeloid leukemia.